The most positive thing right now is they are selling in China again, because they actually have some distribution back now. The old stock has cleared out as well. They should be pushing harder on this front as it is more profitable.
USA is costing them alot to achieve the revenues they are getting. Add in the need/costs for FDA approval, marketing, logistics, tariffs etc and it just seems unsustainable for a company that is burning cash.
You say it will be a reaper in a year or two, well how many more capital raises is that?
BUB Price at posting:
11.5¢ Sentiment: Hold Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)